Exsurco Medical Excision Technology featured in CEOCFO Magazine

August 2019

We are excited to be a featured company in the CEOCFO Magazine's recent publication:

The article features highlights on our company, our product, and our employees' mission to save and improve lives through the Healing Power of Skin.


ExsurcoMedical Aug 2019-CEOCFOMagazine-Interview

About Exsurco Medical, Inc.

In 2015, Exsurco Medical moved into its own production facility, a standalone space with a Class 7 cleanroom for assembling and packaging in Wakeman, OH. Exsurco Medical also is registered with the FDA and is ISO 13485:2016 certified.  Exsurco Medical’s mission is to advance incision science to improve the lives of patients in need of the healing power of skin. In 2017, the company launched a new wound debridement and skin grafting medical device, the Amalgatome SD® for use in burn and trauma centers. The product is currently in use in burn centers across the United States.